In News: Department of Biotechnology (DBT), Biotechnology Industry Research Assistance Council (BIRAC) are organizing Global Bio-India 2021.
- It is a mega international congregation of biotechnology stakeholders, including international bodies, regulatory bodies, Central and State Ministries, SMEs, large industries, bioclusters, research institutes, investors, and the startup ecosystem.
Key Highlights
- Theme: “Transforming lives”
- Tag line: “Biosciences to Bio-economy”.
- The event has representatives from 50 plus countries with Switzerland as the key partner and Karnataka as the state partner.
- Three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science & Technology, and Health & Family Welfare.
- It is the largest Bio event and would showcase opportunities in Indian Biotechnology sector to the world.
- Multiple products by the private sector like Tech- Ola were launched.
- Tech-Ola is a single window e- marketplace app, which would bring together all public and private sector laboratories, fabrication and prototyping centres.
- Indian capability in Vaccine Production was applauded by WHO delegates.
- India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines.
- As many as 30 vaccines are at different stages of development in India.
- Vaccines already in use are
- Covaxin, developed indigenously by Bharat Biotech.
- Covishield, developed by Oxford-AstraZeneca and being manufactured at Serum Institute of India.
- Project Development Cell for Biotechnology was announced
- Two Reports were released:
- ‘Indian Bioeconomy Report (IBER)’ by Association of Biotechnology Led Enterprises (ABLE), not-for-profit pan-India forum.
- ‘Biotech Investment Potential for Indian States Report’ by IFC
- Growth in the biotech sector with 850+ startups in the last year alone is encouraging.
About Biotechnology
|
Source: PIB
Previous article
Marine Spatial Planning
Next article
Facts in News